The global Phase 3 MOTION study (NCT05059262) aims to evaluate the efficacy and safety of vimseltinib for the treatment of TGCT in cases where surgical removal of the tumor is not an option.

Khaled El-Enany, the agency’s first director-general from an Arab state, will lead the UN’s education, science and cultural organization through one of its most severe tests.

Epidemiological and biological plausibility studies support a cause-and-effect relationship between increased levels of physical activity or cardiorespiratory fitness and reduced coronary heart ...

Abstract: Cyber-Physical Systems (CPS) are integrations of computation and physical processes. Embedded computers and networks monitor and control the physical processes, usually with feedback loops ...

Emerging evidence indicates that sustainable lifestyle changes—such as increasing physical activity, adopting healthy dietary ...

Harbaji, W. and Abdulai, A. (2025) Factors Influencing Schoolchildren’s Obesity: A Qualitative Document Analysis of ...

Mississippi has launched the REACH MS virtual teacher programme to address its critical teacher shortage. Through a $2.2 ...

Phonons are indeed recognized as vibrations of the lattice that transport heat energy in solids. To contemplate on the idea ...

Abington Heights Sixth grader Leah Puttcamp is excelling academically and in both BMX and mountain bike racing, according to school officials. Over her young career she has more than 70 top-five ...

Both experts said that with the consistent use of collagen-boosting skin care actives like retinoids, the textural ...

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and ...